MLN4924 (pevonedistat)

pevonedistat · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MLN4924 (pevonedistat), covering 2013-12-05 to 2013-12-05. Get the full timeline:

Most recent: Clinical Trial Update: MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia [Phase 1]

See pricing